NCT00025909View on ClinicalTrials.gov

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2001

Study Completion Date

January 31, 2005

Conditions
HIV Infection
Interventions
PROCEDURE

Leukapheresis

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00025909 - Intermittent vs. Continuous HAART to Treat Chronic HIV Infection | Biotech Hunter | Biotech Hunter